401
Participants
Start Date
October 31, 2005
Primary Completion Date
June 30, 2006
Study Completion Date
July 31, 2006
rThrombin
1000 U/mL applied topically in combination with absorbable gelatin sponge
bovine thrombin
1000 U/mL applied topically in combination with absorbable gelatin sponge
Mt. Sinai School of Medicine, New York
University of Pittsburgh Medical Center, Pittsburgh
University of Virginia, Charlottesville
Duke University Medical Center, Durham
Baptist Clinical Research, Pensacola
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Cardio Thoracic Surgeons, P.C., Birmingham
Cardio Thoracic Surgeons, P.C., Medical Center East / Baptist Montclair, Birmingham
University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
Bluegrass Orthopedics/Bluegrass Musculoskeletal Research, Lexington
Indiana Spine Group, Indianapolis
VAMC Clinical Research Center, Detroit
Northwestern Memorial Hospital, Chicago
Northwestern University Vascular Surgery, Chicago
Washington University School of Medicine, St Louis
Tulane University Abdominal Transplant, New Orleans
Vascular Surgery Associates, Baton Rouge
University of North Texas Science Center at Fort Worth, Fort Worth
Clinical Trials of Texas, San Antonio
Physician's Research Options, LLC/The Intermountain Spine Institute, Murray
University of Utah, Salt Lake City
University of Southern California, Keck School of Medicine, Los Angeles
University of Southern California, Keck School of Medicine, Los Angeles
Methodist Hospital, Arcadia
Huntington Memorial Hospital, Pasadena
Glendale Adventist Medical Center, Glendale
Virginia Mason Medical Center, Seattle
Harborview Medical Center, Seattle
Lead Sponsor
ZymoGenetics
INDUSTRY